Pheochromocytomas are adrenal medullary tumors which arise from the transformation of neural crest-derived cells. In the course of studies of mice transgenic for an SV40 T-gene ectopically expressed in the adrenal medulla, we observed the occurrence of large, mainly bilateral tumors in a high proportion of transgenic animals. From these tumors we established immortalized cell lines which grow in vitro at 328C (the permissive temperature for the tsA58 T-protein encoded by the transgene), but not at 388C. These cells demonstrate characteristics of both neuronal (160 kd neuro®lament) and endocrine (chromogranins) cells. The expression of Mash-1 and ret supports their initial characterization as early bipotential neuro-endocrine progenitors.
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The neural crest is a transient feature, arising on top of the neural tube during embryonic development and then disappearing as the various cell types dierentiate and migrate to their ®nal destination. The multipotent neural crest cell becomes committed to cell types of a number of dierent lineages including the peripheral nervous system, melanocytes and facial bone mesenchyme. The adrenergic endocrine cells (chroman cells) of the adrenal medulla and noradrenergic neurons of the paravertebral sympathetic ganglia derive from the sympathoadrenal region of the crest (Landis and Patterson, 1981) . A third cell, somewhat intermediate in character between neurons and chroman cells has been identi®ed (Anderson, 1989) , which can be made to dierentiate into either chroman cells or neurons (Doupe et al., 1985b) depending on which cytokine signal they receive. Dierentiation towards a chroman cell is promoted by glucocorticoids (Eranko et al., 1972; Doupe et al., 1985a,b) whereas neuronal dierentiation is enhanced by nerve growth factor (NGF) (Unsicker et al., 1978; Doupe et al., 1985a) and basic ®broblast growth factor (bFGF) (Claude et al., 1988; Stemple et al., 1988) . These observations suggest that the various sympathoadrenal cell types are derived from a common progenitor, rather than each differentiating independently from the neural crest progenitor (Landis and Patterson, 1981; Anderson, 1989; Unsicker et al., 1989) . In humans several types of tumor are known to be derived from the neural crest.
These include neuroblastomas, medullary thyroid carcinomas (MTC) and pheochromocytomas (adrenal medullary tumors). These tumors share the characteristic features of expressing the ret protooncogene (Ikeda et al., 1990; Santoro et al., 1990) , and germline mutations of ret are detectable in inherited syndromes such as FMTC (familial medullary thyroid carcinoma), MEN2A and MEN2B (in which MTC is often accompanied by pheochromocytoma and ganglioneuromas, respectively) (van Heyningen, 1994) . This study was initiated with the intent of establishing lines of transgenic mice that may allow us to identify elements responsible for cell type and developmental speci®city of the expression of GATA-1, a gene encoding a hematopoietic transcription factor essential for the development of erythroid cells. Transgenic lines were produced using either a wildtype or a mutant SV40 T-gene (tsA58) (Jat et al., 1991) , driven by the promoter-enhancer region of GATA-1 (Cairns et al., 1994) . The mutant T-gene encodes a themosensitive protein that is almost completely inactivated at mouse body temperature, but is fully active at 328C. These mice were hematologically normal; from their bone marrow it was possible to derive, at 328C, immortalized hematopoietic progenitor cell lines, which appropriately express the T-gene (Cairns et al., 1994) . Eighteen independent positive transgenics were identi®ed by Southern analysis. Unexpectedly at approximately 3 ± 4 months of age a number of founder transgenics died. These animals were analysed and massive unilateral or bilateral adrenal hyperplasia was observed. The tumors were well contained within a capsule and had not invaded the adjacent kidney. No other pathological defect was obvious in these animals. The largest tumors were found in animals which had died spontaneously; smaller tumors were observed when animals were sacri®ced for analysis indicating that in the latter case the tumor was probably the cause of death. Tumors developed with approximately the same frequency in animals with either the thermosensitive (four out of seven founders; three bilateral, one unilateral) or the wild-type (six out of eleven founders; two unilateral, four bilateral) construct. Histological analysis of tissue sections taken from these tumors demonstrated that the normal architecture of the adrenal gland had been completely disrupted; the predominant cell type appeared poorly dierentiated and no distinction between cortical and medullary areas was evident.
A number of cell lines were established from the freshly isolated adrenal tumors, which arose in animals containing either the wild-type (T wt cells) or thermosensitive (tsA58 cells) constructs. Whereas the T wt cell lines were routinely cultured at 378C, tsA58 cell lines were maintained at 328C, the permissive temperature for tsA58 activity. Under both conditions the cells grew as an aderent monolayer with bilateral and occasionally radiating processes (Figure 1a) . At the ultrastructural level the cells contained large ovoid or round, dense core granules with a diameter ranging from 50 ± 200 nm (data not shown), which resemble chroman vesicles or adrenal medullary cells.
At early passages, the tsA58 cells were strictly dependent on the temperature, with a doubling time of approximately 30 h and reaching saturation point at approximately 1.4610 6 cells per 0.6 cm petri dish. When switched to 388C they rapidly (within 3 ± 4 days) underwent dramatic morphologic changes (Figure 1b) , and slowed down their growth rate 2 ± 3-fold, as assessed by the MTT assay (Mosmann, 1983) eventually dying (after approximately 14 days). These results indicate that the immortalisation of these cells is dependent on SV40 T activity. At later passages, the cells were no longer strictly temperature dependent and could be cultured at 388C, although at this temperature they showed some morphological changes. To assess the ability of the tsA58 cells to form colonies in agar, we plated 1610 6 and 1610 7 cells subcutaneously into the¯anks of nude mice. Tumor growth was assessed over a period of 3 months; no tumors were detected. Ecient cell growth in agar often correlates with tumorigenicity in vivo; the discrepancy in this case possibly re¯ects cell deterioration and apoptosis as a result of the switch to 388C, the in vivo body temperature; this is also observed in vitro.
The tsA58 cell lines were further analysed by immuno¯uorescence for their expression of markers characteristic of adrenal medullary cells or sympathetic progenitors. Chromogranin A and B are secretory proteins costored with various peptide hormones and neuropeptides in secretory granules of many endocrine cells and neurons (Eiden et al., 1987) . Both these proteins are present in tsA58 cells (Figure 2a) . Chromogranin A was detectable in most of the cells where it appears to be predominantly localized within the processes. Chromogranin B is detectable in many of the cells (70%) and shows an even distribution over the cytoplasm. Another secretory protein, (VGF8) (Possenti et al., 1989) was instead absent.
Among neuronal markers only the 160 kd neurofilament (NF 160 kd) was positive, whereas both the 200 kd and 220 kd neuro®lament markers and the neuronal speci®c enolase were undetectable. In early passage cells NF 160 kd was clearly detected in untreated cells (Figure 2c ), whereas with later pasage cells the staining was diminished and the cells remained only weakly positive (see Figure 3a) . As expected, all cells expressed T-antigen (Figure 2d ). tsA58 cells synthesize the neurotransmitter noradrenaline and its precursor L-Dopa as both were detected in cell extracts at very low levels, 7.7 pg/mg of cell protein and 50.4 pg/mg of cell protein respectively. Adrenalin was undetectable in cell extracts.
To explore the action of various cytokines on adrenal tumor cells we ®rst examined the individual eects of NGF (2.5S) and basic FGF on cell growth and morphology in a basal medium containing 10% FCS for 7 days on late passage cells. Control, untreated cells grow adherently with bilateral or radiating processes. After treatment with bFGF for 7 days the cells become noteably more spread and obvious neuro®laments positively stained with the NF a b Figure 1 Morphological appearance of tsA58 adrenal cells cultured at 328C (a) and at 388C (b) for 3 days in DMEM and 10% FCS. Original magni®cation 4006 160 kd marker could be seen within the cytoplasm (Figure 3b ). Addition of NGF to the culture medium, for 7 days, caused the cells to become generally more condensed with compact round cell bodies and elongated processes; NF 160 kd was clearly positive within these processes. Both treatments resulted in a little or no increase in growth rate when measured over a 7 day period. When cells were incubated primarily with bFGF alone for 60 h followed by the addition of NGF or with bFGF and NGF together similar results were obtained as to those with NGF alone. After both treatments, the cells display long, NF 160 kd positive processes protruding out from a relatively compact cell body (Figure 3c ). Thus these studies reveal that in response to either NGF, FGF or a combination of both these cells are able to modulate their phenotype and to initiate neuronal differentiation.
To further characterize these cells, we looked by Northern blot analysis at the expression of a number of genes known to be active in neural crest derivatives. Among these, peripherin SCG10 and VGF8 were all negative or very weak; however Mash-1, a neural transcription factor (Johnson et al., 1990) , and ret (Takahashi and Cooper, 1987) , a membrane receptor for glial cell-line-derived neurotrophic factor (GDNF) (Trupp et al., 1996) were positive (Figure 4) . The expression of these molecules was examined under relatively sparse (50% con¯uency) or subcon¯uent conditions, after treatment with NGF and/or FGF as indicated in Figure 3 . No signi®cant changes were observed.
In this report we describe the unexpected development of tumors of the adrenal medulla in transgenic mice in which the promoter-enhancer region of the gene encoding GATA-1, a transcription factor restricted to the hematopoietic system and to Sertoli cells of the testis (Orkin, 1995; Yomogida et al., 1994) , was used to direct expression of the SV40 large T-gene to a selected population of hematopoietic cells. Both the wild-type and the tsA58 T-proteins induced tumors; the eect of the thermosensitive protein in vivo is not totally unexpected, as complete inactivation does not occur at the mouse body temperature and tumors are therefore known to result (Robinson et al., 1994) .
Several possible explanations might be put forward to explain the unusual tissue speci®city of the GATA-1 promoter/SV40 transgene in these tumors. Integration of the transgene at a site which is transcriptionally active within cells of the adrenal medulla resulting in over expression of this transgene could account for the observed adrenal tumors. However, as such an event would be random one would expect such lesions to occur with a very low frequency and probably only in a unique line of transgenic mice. The ®nding that these The GATA-1 driven tsA58 is transcribed, although at a relatively low level, in the immortalized adrenal cells (Figure 2 and data not shown). From previous experiments we know that in hematopoietic cells, high level expression is con®ned to early progenitors and erythroid precursors, whereas strong inhibition of the expression of this construct occurs concomitantly with myeloid dierentiation (Cairns et al., 1994) , indicating appropriate regulation. However we cannot rule out the possibility that a small level of transcription occurs in at least some non-hematopoietic tissues, particularly in animals with a large number of integrated constructs. Medullary adrenal progenitors contain two additional members of the GATA family of transcription factors, GATA-2 (Groves et al., 1995) and GATA-3 (George et al., 1994) , which might stimulate T-gene expression by cross-activation of the GATA-1 binding site critical for the activity of the enhancer present in our construct (Cairns et al., 1994) . In addition, the development of tumors speci®cally in the adrenal medulla might re¯ect a higher sensitivity of this tissue to transformation by even low levels of SV40 T-protein. Indeed the T-gene exhibits a high transforming activity for cells of the CNS (Babinet et al., 1989) and its expression has frequently resulted in tumors of neuronal tissue origin, whether the gene was driven by promoters for genes expressed in neuronal or extra-neuronal tissues (Bottari et al., 1987; Shalnik et al., 1991) . Transgenic mice expressing the SV40 T-gene ubiquitously under the Expression of ret and Mash-1 RNA tsA58 adrenal cells. Cells were grown at 50% or 80% con¯uency in the presence of FGF, NGF or FGF+NGF at the same concentrations as in Figure 3 for 7 days. Total RNA was extracted according to Chomczynski and Sacchi (1987) ; 10 mgm of RNA were electrophoresed through 1% agarose 2.2 M formaldehyde denaturing gels in MOPS buer, blotted in 106SSC to Hybond N membranes (Amersham International), and cross linked to the dried membranes by u.v. irradiation, and the membranes baked at 808C for 15 min. Prehybridization, hybridization and washing of membranes was performed according to Church and Gilbert (1984) . The following DNA probes were radioactively labeled by random priming: a full length cDNA fragment of murine Mash-1 ; a mouse ret cDNA (Takahashi and Cooper, 1982) , and a mouse b-actin probe. Following hybridization with the ret or Mash-1 probes, the ®lters were hybridized to the actin probe for normalization. Lanes 1 and 2 control untreated cells; lanes 3 and 4 NGF treatment; lanes 5 and 6 FGF treatment; lanes 7 and 8 NGF+FGF treatment. Lanes 1, 3, 5 and 7 represent cells at 50% con¯uency; lanes 2, 4, 6 and 8 represent cells at 80% con¯uency control of an interferon-g dependent promoter have been available for several years (Jat et al., 1991) , but so far no reports of immortalized neural crest-derived cell lines have been published. It is possible that our construct is expressed at a stage early enough to`trap' neural crest progenitors before they reach a stage of dierentiation incompatible with immortalization. This is in agreement with our previous data demonstrating that the same construct, when expressed in the hematopoietic system, immortalizes early multipotential progenitors, but not more dierentiated cells (Cairns et al., 1994) . The adrenal tumors which developed in these transgenic animals, show many characteristics with mixed neuroblastoma or primitive neuroectodermal tumors (pheochromocytoma), consistent with a primitive neuroectodermal origin, including the expression of the antigenic markers 160 kd neuro®lament, chromogranin A and chromogranin B and the production of low levels of dopa and noradrenalin. However, many dierentiated neuronal or adrenal medullary characteristics are essentially absent from cell lines derived from these stages, as indicated by lack of signi®cant expression of other neuro-endocrine markers (peripherin, SCG10, VGF8, adrenalin and noradrenalin).
To better characterize the stage(s) of which our cells are blocked, we analysed the expression of markers of early sympatho-adrenal precursors. Two such markers were positive by Northern blot analysis: Mash-1 and ret. The Mash-1 gene encodes a basic helix ± loop ± helix transcription factor that is transiently expressed during central (CNS) and peripheral (PNS) nervous system development in the mouse (Johnson et al., 1990; . Mash-1 is expressed at embryonic day 9.5 (E9.5) in neural crest-derived precursors of sympathetic ganglia and at E12.5 in the adrenal medulla . A null mutation of Mash-1 results in some decrease of the size of the medulla and in a block of neuronal dierentiation in sympathetic ganglia .
In normal development, ret is expressed in the undierentiated, migrating neuroectodermal precursors and subsequently in the anlage of the sympathetic ganglia (Pachnis et al., 1993) ; signi®cantly, at E-10.5 ret expression appears to mark Mash-1 positive cells (or their immediate precursors) in developing sympathetic ganglia . The positivity of our cells for Mash 1 and ret, taken together with their ability to express both a neural marker (160 kd neuro®lament) and the neuroendocrine proteins Chromogranin A and B, suggests that these tumors derive from a neuroectodermal progenitor transformed at an early stage of populating the adrenal primordium. Such a cell type, a bipotential precursor to both chroman and symphathetic neurons with a transiently dual phenotype, has been isolated from E11.5 rats. This cell will subsequently repress expression of the neuronal or chroman markers depending on the environmental cues which it receives i.e. growth factor derived stimuli and according to its ®nal choice of cell fate (Anderson, 1993; Ip et al., 1994) . ret expression, although present in sympathetic progenitors, is extinguished in adrenal chroman cells (Pachnis et al., 1993) ; the fact that our cells express a relatively high level of ret mRNA suggests that a high proportion of the transformed cells are blocked at an early stage of their dierentiation. Initial experiments with GDNF, the ret ligand, resulted in little or no eect on cell growth or morphology. It has recently been reported that a novel membrane protein, GDNFR-a is Ret's partner in ligand binding and is an obligatory part of the signaling receptor (Treanor et al., 1996; Jing et al., 1996) ; under basal conditions our cells do not express GDNFR-a mRNA as evaluated by RT ± PCR (not shown) and this may explain the lack of response of our cells to GDNF.
On the other hand experiments with our in vitro population suggest that these cells may undergo some morphological changes in the presence of FGF and NGF (Figure 3) but not complete dierentiation. FGF induces proliferation and neurite outgrowth on chroman cells, but is unable to support long-term survival and full neuronal dierentiation (Claude et al., 1988; Stemple et al., 1988) . Similarily in the rat sympathoadrenal progenitor cell line MAH, FGF is able to induce initial neuronal dierentiation and to sensitize a small minority of cells to undergo terminal dierentiation in response to NGF (Birren and . On the other hand, NGF alone is able to induce terminal dierentiation of the rat pheochromocytoma cell line PC12 (Greene and Tischler, 1976) . It is possible that in our cells additional factors such as ciliary neurotrophic factor (CNTF) (Ip et al., 1994) may be required for terminal dierentiation. Alternatively the interaction of SV40 Tantigen with other cellular proteins critical for cell cycle regulation and cell survival, such as retinoblastoma and p53 may be dicult to overcome by simply switching the cells to the inactivating temperature. Indeed, obtaining full dierentiation of SV40 ts T-gene immortalized neuronal precursors has proven dicult, and addition of cytokines, growth on speci®c substrates or forskolin treatment are normally required in addition to switching to the non-permissive temperature (White et al., 1994) . We are presently looking at the possibility of inducing terminal dierentiation with growth factor treatment coupled with temperature shift.
